Results 11 to 20 of about 74,283 (261)

Implementation costs of a multi-component program to increase human papillomavirus (HPV) vaccination in a network of pediatric clinics [PDF]

, 2020
Introduction: HPV vaccination is both a clinically and cost-effective way to prevent HPV-related cancers. Increased focus on preventing HPV infection and HPV-related cancers has motivated development of strategies to increase adolescent vaccination rates.
Eska, Jarrod S, Fernandez, Maria E, Healy, C Mary, Lairson, David R, Savas, Lara S., Shegog, Ross, Spinner, Stanley W, MD, Vernon, Sally W.   +7 more
core   +2 more sources

Knowledge About the Human Papillomavirus Vaccine Among Employees at a Tertiary Cancer Center: Room for Improvement [PDF]

, 2020
Introduction: The human papillomavirus (HPV) vaccine is recommended by the U.S. Centers for Disease Control and Prevention for routine vaccination of boys and girls to protect against HPV-related cancers and genital warts. To meet the Healthy People 2020
Baum, George P, Bello, Rosalind S, Dahlstrom, Kristina R, DePinho, Ronald A, Hawk, Ernest, Ramondetta, Lois M, Stevens, Lori D, Sturgis, Erich M, Tamez, Elenita   +8 more
core   +2 more sources

Using Intervention Mapping to Develop an Efficacious Multicomponent Systems-Based Intervention to Increase Human Papillomavirus (HPV) Vaccination in a Large Urban Pediatric Clinic Network [PDF]

, 2020
Background: The CDC recommends HPV vaccine for all adolescents to prevent cervical, anal, oropharyngeal, vaginal, vulvar, and penile cancers, and genital warts. HPV vaccine rates currently fall short of national vaccination goals.
Coan, Sharon P., Crawford, Claire A., Frost, Erica L., Gabay, Efrat K., Healy, C. Mary, Savas, Lara S., Shegog, Ross, Spinner, Stanley W., Vernon, Sally W.   +8 more
core   +2 more sources

Special Issue: HPV and HPV Vaccines [PDF]

Viruses, 2022
Our fundamental understanding of papillomaviruses and their interactions with their host, including their role in cancer and how the immune system responds to them, has made the elimination of cervical cancer a realistic global health goal [...]
openaire   +3 more sources

Acceptability and readiness to promote human papillomavirus vaccination at ages 9–10 years: a feasibility study among North Carolina clinics

Pilot and Feasibility Studies, 2023
While 9-valent human papillomavirus (HPV) vaccination is approved by the US Food and Drug Administration for use in adolescents as young as age 9, providers typically recommend it at ages 11–12.
Nadja A. Vielot, Robyn M. Lane, Kaitlyn Loefstedt, Jennifer L. Cunningham, Jason Everson, Eli Tiller, Sarah E. Johnson Patel, Jennifer S. Smith   +7 more
doaj   +1 more source

Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium

BMC Public Health, 2016
Background Although female sex workers (FSWs) are a well-known high-risk group for Human Papillomavirus (HPV) infections, few tailored intervention programmes for HPV have been established worldwide. The lack of reliable data on the prevalence of HPV and
Alex Vorsters, Tine Cornelissen, Elke Leuridan, Johannes Bogers, Davy Vanden Broeck, Ina Benoy, Herman Goossens, Niel Hens, Pierre Van Damme   +8 more
doaj   +1 more source

Human Papillomavirus (HPV) Vaccination Knowledge, Beliefs, and Hesitancy Associated with Stages of Parental Readiness for Adolescent HPV Vaccination: Implications for HPV Vaccination Promotion

Tropical Medicine and Infectious Disease, 2023
The vaccination against human papillomavirus (HPV) has shown effectiveness in preventing six different types of cancer. Despite a safe, effective HPV vaccine, vaccination coverage for adolescents remains suboptimal, especially in the Memphis, Tennessee ...
Seok Won Jin, Yeonggeul Lee, Heather M. Brandt   +2 more
doaj   +1 more source

Factors Influencing Human Papillomavirus Vaccination Among Asian Immigrant College Students During the COVID-19 Pandemic

SAGE Open, 2023
Despite strenuous efforts to increase vaccination rates against human papillomavirus (HPV), the rate of vaccination remains low in the U.S. The COVID-19 pandemic poses an additional challenge to HPV vaccination.
ShinHi Han, Hee Sun Kang, Koun Eum, Jin Young Seo, Kathleen Karsten   +4 more
doaj   +1 more source

Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China

Frontiers in Immunology, 2023
BackgroundThe 2021 Chinese Expert Consensus on the Clinical Application of the Human Papillomavirus (HPV) Vaccine recommended vaccination for women who previously received ablative or excisional treatment for high-grade squamous intraepithelial lesion ...
Maosheng Zou, Hanting Liu, Huan Liu, Mengjie Wang, Zhuoru Zou, Lei Zhang, Lei Zhang, Lei Zhang   +7 more
doaj   +1 more source

Factors Influencing HPV Vaccination Intention in Mothers with Elementary School Daughters [PDF]

Korean Journal of Women Health Nursing, 2019
PURPOSE: The purpose of this study was to identify the impacts of human papillomavirus (HPV) vaccination-related health belief, attitudes toward HPV vaccination, and subjective norms on HPV vaccination intent targeting mothers of elementary school ...
Sun Hwa Kim, Mi Hae Sung, Yun Ah Kim, Hye Jin Park   +3 more
doaj   +1 more source